Sphera Funds Management’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Sphera Funds Management’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-16,445	Closed	-$105K	–	125
2023 Q4	$105K	Buy	+16,445	New	+$88.1K	0.02%	97

Sphera Funds Management's FRLN Position: Q1 2024 in Review

Sphera Funds Management sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2024, closing a stake of 16,445 shares — an estimated $105K sold.

Sphera Funds Management first reported a position in FRLN in Q4 2023 and held it in 1 quarter. The position peaked at $105K in Q4 2023. 0 funds tracked by Wall St. Rank hold FRLN as of Q1 2024.

Sphera Funds Management reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Sphera Funds Management sold 16,445 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2024, an estimated $105K.
Sphera Funds Management first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
Sphera Funds Management's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $105K in Q4 2023.
0 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2024.

Based on Sphera Funds Management's 13F filing for Q1 2024, filed 15 May 2024.